Home / Business and Economy / Indian Pharma Makes Biggest Acquisition Ever
Indian Pharma Makes Biggest Acquisition Ever
28 Apr
Summary
- Sun Pharma is acquiring US-based Organon for $11.75 billion.
- This deal represents the largest acquisition by an Indian pharmaceutical company.
- The acquisition significantly boosts Sun Pharma's global presence.
Sun Pharma, under the leadership of Dilip Shanghvi, has entered into an agreement to acquire the US pharmaceutical company Organon. This significant all-cash transaction is valued at $11.75 billion, with each share of Organon priced at $14.
The acquisition represents a monumental step for Sun Pharma, establishing it as the largest-ever acquisition made by an Indian pharmaceutical firm. This strategic move is poised to propel Sun Pharma's global expansion efforts considerably.
Through this deal, Sun Pharma gains substantial entry into the United States' women's healthcare sector. Furthermore, it solidifies and enhances the company's market presence across vital international regions, including China, Europe, Korea, and Latin America.
